Ashley Arthur Woodcock
Founder at Reacta Biotech Ltd.
Ashley Arthur Woodcock active positions
| Companies | Position | Start | End |
|---|---|---|---|
North West Lung Centre
 North West Lung Centre Medical/Nursing ServicesHealth Services North West Lung Centre provides services related to other human health activities. | Director/Board Member | - | - |
Reacta Biotech Ltd.
 Reacta Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Reacta Biotech Ltd. engages in a biotechnology company. It develops, manufactures, and commercializes oral food challenge materials to pharmaceuticals standards of Good Manufacturing Practice (GMP). The company was founded by Clare Mills, Ashley Woodcock, and Peter McPartland in June 2013 and is headquartered in Deeside, the United Kingdom. | Chairman | 2013-05-31 | - |
| Founder | 2013-05-31 | - | |
| Axalbion SA | Chairman | - | - |
Axalbion Therapeutics Ltd.
 Axalbion Therapeutics Ltd. BiotechnologyHealth Technology Axalbion Therapeutics Ltd. has developed a drug candidate for several therapeutic applications. The private company is based in Wythenshawe, UK. The British company has evaluated new patented TRPM8 agonists, which are molecular transducers expressed in sensory neurons. The TRPM8 ion channel is expressed by approximately 10-15% of somatosensory neurons. Axalbion Therapeutics focuses on treating dry eye syndrome (DES), which is a disorder of the tear film due to tear deficiency. The company was founded in 2021, and the CEO is Michael M. Kitt. | Chairman | - | - |
Career history of Ashley Arthur Woodcock
Statistics
International
| United Kingdom | 4 |
| Switzerland | 2 |
Operational
| Chairman | 3 |
| Director/Board Member | 1 |
| Founder | 1 |
Sectoral
| Commercial Services | 2 |
| Health Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
Reacta Biotech Ltd.
Reacta Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Reacta Biotech Ltd. engages in a biotechnology company. It develops, manufactures, and commercializes oral food challenge materials to pharmaceuticals standards of Good Manufacturing Practice (GMP). The company was founded by Clare Mills, Ashley Woodcock, and Peter McPartland in June 2013 and is headquartered in Deeside, the United Kingdom. | Commercial Services |
North West Lung Centre
North West Lung Centre Medical/Nursing ServicesHealth Services North West Lung Centre provides services related to other human health activities. | Health Services |
| Axalbion SA | |
Axalbion Therapeutics Ltd.
Axalbion Therapeutics Ltd. BiotechnologyHealth Technology Axalbion Therapeutics Ltd. has developed a drug candidate for several therapeutic applications. The private company is based in Wythenshawe, UK. The British company has evaluated new patented TRPM8 agonists, which are molecular transducers expressed in sensory neurons. The TRPM8 ion channel is expressed by approximately 10-15% of somatosensory neurons. Axalbion Therapeutics focuses on treating dry eye syndrome (DES), which is a disorder of the tear film due to tear deficiency. The company was founded in 2021, and the CEO is Michael M. Kitt. | Health Technology |
